🇺🇸 FDA
Pipeline program

Conventional third-line therapy

ISL2024313

Unknown other active

Quick answer

Conventional third-line therapy for Colorectal Cancer (CRC) is a Unknown program (other) at The First People's Hospital of Lianyungang with 1 ClinicalTrials.gov record(s).

Program details

Company
The First People's Hospital of Lianyungang
Indication
Colorectal Cancer (CRC)
Phase
Unknown
Modality
other
Status
active

Clinical trials